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Abstract
In August 2012, the National Institute for Health and Care Excellence produced positive diagnostics guidance on the
ultrasound contrast agent SonoVue, but recommended further research involving an estimation of the proportion of
unenhanced ultrasound scans reporting, but not characterising, focal liver lesions, particularly in cirrhotic livers. Patient
records from the Radiology Information System of an acute hospital trust were progressively filtered based on categorical
fields and keywords in the free text reports, to obtain ultrasound records including the liver that were appropriate for
manual analysis. In total, 21,731 records referred from general practice or out-patient clinics were analysed. Patients
described as having cirrhosis were analysed as a subgroup. After automatic exclusion of records considered likely to be
negative, 5812 records were manually read and categorised as focal liver lesion inconclusive, benign or malignant. In the
general practice cohort of 9175 records, 746 reported the presence of one or more focal liver lesions, with 18.4% (95% CI
15.7% to 21.3%) of these records mentioning an inconclusive focal liver lesion. In the out-patient cohort of 12,556 records,
1437 reported one or more focal liver lesions, and 29.4% (95% CI 26.9% to 32.0%) of these were inconclusive. Cirrhosis
was reported in 10.8% of the out-patient scans that also reported a focal liver lesion, and 47.4% (95% CI 39.3% to 55.6%)
of these scans had an inconclusive focal liver lesion, compared with 27.3% (95% CI 24.9% to 29.8%) that were inconclu-
sive in non-cirrhotic livers (odds ratio 2.4; 95% CI 1.7 to 3.4). This retrospective study indicates that unenhanced ultra-
sound scans, in which a focal liver lesion is detected, are frequently inconclusive, with the probability of an inconclusive
scan being greater in out-patient than general practice referrals. Inconclusive focal liver lesions were also reported in
greater proportions of cirrhotic than non-cirrhotic livers. The results of this research will inform future updates of National
Institute for Health and Care Excellence diagnostics guidance.
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Introduction
Ultrasound examinations of the abdomen routinely
interrogate the liver to identify abnormal morphology or
hepatic pathology. Occasionally, ultrasound of the liver
may reveal the presence of a focal liver lesion (FLL), which
can be either malignant or benign. However, it is not always
possible for unenhanced ultrasound to correctly identify the
nature of an FLL, and further characterization may be neces-
sary to determine the appropriate patient management.
Typically, FLLs that require further characterization are
investigated using contrast-enhanced ultrasound (CEUS),
contrast-enhanced computed tomography (CECT), or con-
trast-enhanced magnetic resonance imaging (CEMRI).1
In August 2012, a contrast agent, SonoVue sulphur hex-
afluoride microbubbles (Bracco Imaging S.p.A), for CEUS,
was assessed and given a positive recommendation by the
National Institute for Health and Care Excellence (NICE) for
use with liver imaging (NICE diagnostics guidance
number 5).2 The evidence used to formulate the recommen-
dations was derived from a systematic review and an asso-
ciated cost utility model, which incorporated three
economic scenarios to assess the cost-effectiveness of
SonoVue. That work has since been published as a
Health Technology Assessment (HTA).3 The scenarios
were: (i) detection of metastases following diagnosis of colo-
rectal cancer; (ii) incidental detection of FLLs in people with
non-specific indications; and (iii) cirrhosis surveillance,
which incorporated an adaptation of a previously published
model.4 Cirrhosis surveillance has been shown to be posi-
tively associated with increased survival rates by a recent
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systematic review and meta-analysis of observational
studies.5
An important parameter used specifically in the cirrhosis
surveillance model was the proportion of ‘inconclusive’
unenhanced ultrasound scans; NICE defined an inconclusive
scan as ‘an unenhanced ultrasound scan in which a FLL is
detected, but not characterised’. The manufacturer of
SonoVue provided an estimate that 43% of ultrasound
scans were inconclusive, and therefore require further diag-
nostic investigation. This estimate aligned with a previous
study by Strobel et al.,6 which compared the diagnostic
accuracy of unenhanced Doppler ultrasound with Doppler
ultrasound with CEUS (contrast medium used not
SonoVue) in patients with known FLLs and with a high
suspicion of malignancy (cirrhosis status not reported).
However, there was a considerable degree of uncertainty
regarding the 43% estimate as applied to UK clinical practice,
because of the methodology employed, the technology used
and the population recruited in the study. A different esti-
mate of this parameter could substantially affect the cost-
effectiveness estimates of using SonoVue in the cirrhosis
cohort using existing economic models.3
To address this uncertainty, NICE recommended that fur-
ther research should be undertaken on ‘the percentage of
unenhanced ultrasound scans that are inconclusive, particu-
larly in people with cirrhosis’.2 To achieve this, NICE com-
missioned further research through their research facilitation
framework, using an external assessment centre. The assess-
ment centre is free to undertake the research using the most
appropriate methodology, but the work is required to be
practical and rapid, in order to quickly inform updates of
the guidance. This paper reports the work undertaken by
the assessment centre (the authors of this manuscript).
The aim of this study was to answer NICE’s research
question to estimate the probability that an unenhanced
abdominal ultrasound scan report mentions an uncharac-
terized FLL, given that one or more FLLs are detected
during the scan. We define this as the proportion of incon-
clusive scans to match the NICE definition of ‘inconclu-
sive’.2 The setting of the study was a retrospective review
of Radiology Information System (RIS) records of patients
from a hospital trust who received a general ultrasound
examination of the abdomen or a specific scan of the liver.
Additionally, the cirrhosis status of patients, in whom an
FLL was reported, was recorded, to allow for subgroup
analysis to directly answer NICE’s research question.
Materials and methods
Data source and extraction of records
The study was placed on the Newcastle upon Tyne
Hospitals NHS Foundation Trust (NUTH) clinical effective-
ness register as an audit study. Full ethical approval was not
necessary because the primary purpose of the study was to
retrospectively measure service provision without using
identifiable patient information. An extract from the RIS
was provided in spreadsheet format by a radiology data
manager. Using categorical fields (appointment date, exam-
ination and source of referral), potentially relevant records
were extracted for further analysis. Each record included
these three categorical fields, a pseudonymised patient
identifier (unique to each patient) and a free text report
field. Records were included if the appointment date was
between 1 April 2009 and 31 March 2012, the examination
name contained the terms ‘liver’ or ‘abdo’ (abdomen or
abdominal) and the scan modality was ultrasound.
Two distinct cohorts of patients were identified and
included in the study; these were patients referred directly
from their General Practitioner (GP cohort) and patients
referred from secondary care as out-patients (OP cohort).
The GP cohort was considered to be more likely to represent
patients in whom an incidental detection of an FLL might
be made; that is they would be predominantly naı¨ve to
abdominal ultrasound and other imaging modalities.
Those referred as out-patients, however, may have received
previous abdominal imaging, with a prior clinical report
available to the ultrasound operator, or may be undergoing
periodic screening for primary liver cancer (e.g. on a sur-
veillance programme following development of cirrhosis or
infection with hepatitis B or C) or metastatic disease (fol-
lowing diagnosis of an extra-hepatic solid malignancy).
Records from in-patient and accident and emergency refer-
rals were not retrieved, as these were considered to be likely
to represent a particularly complex case-mix. Other than
these restrictions, all patient reports were considered poten-
tially relevant, without further exclusions.
Analysis and classification of records
The process used to analyse and classify records is shown in
Figure 1. There were three stages: (i) exclusion of records
that were out of scope; (ii) identification of records that had
negative detection of FLLs and (iii) classification of the
remaining records in which FLL was detected. Due to the
large number of records, the first two steps were automated
using scripts written in the R programming language.7
Exclusion of records that were out of scope
Using categorical fields, records of scans were removed as
follows: those which were duplicates; those for which the
study name field did not indicate an ultrasound scan of the
abdomen or liver; those not within the specified date range;
and those not in the GP or OP cohorts (identified by the
source of referral field). Using the free text report field, rec-
ords were excluded if the text did not make reference to the
liver or a related adjective (i.e. did not contain any words
starting with ‘liver’, ‘lver’, ‘livr’, ‘hepat’ or ‘lob’). Records
remaining after this first step were considered to be ones
that were likely to have been actively scanned for the detec-
tion of FLLs of the liver. Quality assurance of this filtering
stage was conducted by one researcher manually reading
200 records randomly selected from the exclusions.
Automatic identification of negative findings
Firstly, records were excluded if they did not contain a rele-
vant diagnostic, pathological, or related word (Table 1).
To aid the choice of these terms, a random sample of 200
records was analysed to identify standard text strings or
stored report templates used in the reporting of results.
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In addition, selection of terms was informed by a survey
that was sent out to local sonographers. Quality assurance
of this filtering stage was conducted by one researcher
manually reading 200 random records excluded from this
stage. Secondly, records were automatically counted as ‘FLL
not detected’ if they contained words or phrases in the free
text that were suggestive of the record being negative for
FLLs (Table 2). Quality assurance of this step was con-
ducted by one researcher manually reading a random
sample of 400 of the records counted as ‘FLL not detected’.
Figure 1 Flow chart illustrating progressive exclusion, automatic read and manual read of RIS reports during analysis of ultrasound records
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Manual analysis and classification
Manual analysis consisted of one researcher reading the
remaining reports and classifying them into one of the fol-
lowing categories: FLL not detected; FLL detected but not
characterised (i.e. inconclusive or indeterminate); FLL
detected and characterised as malignant (metastatic or pri-
mary); and FLL detected and characterised as benign.
Cysts, focal fatty sparing, focal fatty infiltration, focal
nodal hyperplasia and haemangiomas were all individually
categorised and collectively classified as benign. Patients
who were identified as having cirrhosis were manually
marked in the data set, to allow for subsequent subgroup
analysis. A random sample of 200 report fields was
extracted and independently read by an experienced con-
sultant radiologist as a further quality assurance step.
Statistical analysis
Confidence intervals of simultaneous multinomial propor-
tions were calculated using the method of Sison and Glaz8
with 95% significance level. Associations between the pres-
ence of cirrhosis and having an inconclusive scan were
tested with Fisher’s Exact Test.
Results
Analysis and classification of records
A total of 504,362 potentially relevant records were
retrieved from the RIS. After removing duplicates, 27,495
records were extracted which were in the date range of
interest, were for ultrasound scans and were for patients
referred by their GP or from out-patient (OP) clinics.
From analysis of the free text report fields of these 27,495
records (Figure 1), 5764 were excluded by the application of
a text filter because they did not contain a word relating to
the organ of interest. A sample of 200 records excluded by
this filter was manually reviewed and none were found to
have been excluded incorrectly. This left 21,731 records of
relevance to this study (9175 in the GP cohort and 12,556 in
the OP cohort).
A total of 3116 records were identified as negative using
a text filter (Table 1), i.e. there was no mention of liver path-
ology. A sample of 200 records, chosen at random from
excluded records, was reviewed manually and none were
found to have been excluded incorrectly. This left 18,615
records which potentially mentioned a FLL.
A total of 12,803 records were identified as having
negative findings of FLLs, using automated text analysis
(Table 2). From a sample of 400 records identified as being
negative for FLL, 12 (3%) were considered to have been
inappropriately excluded by the automatic algorithm. All
of these sampled records, upon manual reading for quality
assurance, were found to contain text indicating a benign
FLL was present, but also contained text indicating a nega-
tive finding in another organ (e.g. no focal lesion of the
kidney). However, this discrepancy was accepted as a rea-
sonable error rate for this step.
This left a total of 5812 records that required manual
review of the report field to determine whether an FLL
was detected and then characterised. On comparing the
Table 2 Terms used to identify records as negative for FLLs (i.e. no FLLs
detected). Two character spaces were allowed between all words
Number Term
1 ‘No focal lesion’
2 ‘No liver lesion’
3 ‘No focal liver lesion’
4 ‘No hepatic focal lesion’
5 ‘No focal hepatic lesion’
6 ‘liver [is] normal in size, contour and reflectivity’
7 ‘Liver and spleen appear normal in size, contour and
reflectivity’
8 ‘No intrahepatic biliary duct dilatation or focal lesions
seen’
9 ‘No intrahepatic biliary duct dilatation or focal liver lesion’
10 ‘No evidence of focal liver lesions or intrahepatic biliary
duct dilatation’
11 ‘No suspicious focal [hepatic/liver] lesion’
12 ‘no evidence of focal liver lesions’
13 ‘no evidence of focal abnormality’
14 ‘liver appears normal in size, contour and reflectivity’
15 ‘liver and spleen appear normal in size, contour and
reflectivity’
16 ‘Normal ultrasound appearances of the liver’
17 ‘Normal appearance[s] of [the] liver’
18 ‘liver, [list of other organs*] normal’
19 ‘Liver of normal size, contour and reflectivity’
20 ‘No abnormality [is] seen in [the] liver’
21 ‘No focal hepatic abnormalit[y or ies]’
22 ‘Normal liver size, contour and texture with no evidence
of focal’
23 ‘No focal hepatic change’
24 ‘Normal size and ultrasound appearances of [the] liver’
25 ‘No gross focal lesion[s] or biliary dilatation’
26 ‘Normal liver,’y
27 ‘Normal appearance[s] of [the] liver’y
*For example ‘liver, spleen, pancreas, gallbladder, biliary tree, aorta and both
kidneys normal’
yReport started with this phrase
Phrases in square brackets were optional
Table 1 Terms used to indicate possible FLL
Term
‘character’, ‘malig’, ‘benign’, ‘staging’, ‘CEUS’, ‘sonovue’, ‘contrast’,
‘imaging’
‘HCC’, ‘carcinoma’, ‘cyst’, ‘hyperplasia’, ‘FNH’, ‘adenoma’, ‘focal’,
‘fcal’, ‘foal’
‘FLL’, ‘lesion’, ‘lsion’, ‘leision’, ‘leison’, ‘leson’, ‘haemang’, ‘hemang’,
‘pathology’
‘metast’, ‘abnormality’, ‘mass’, ‘parenchyma’, ‘disease’, ‘change’,
‘inconc’
‘indetermin’, ‘abscess’, ‘sparing’, ‘infiltration’, ‘neoplasm’, \\<CT*,
‘MRI’)
*\\<CT represents ‘CT’ at the beginning of a word, so was intended to capture a
CT scan
Records containing none of these terms were identified as negative for FLL
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manual read by researcher and experienced radiologist, and
following arbitration on discordant pairs, it was found that
193/200 records were correctly classified by the researcher,
giving an error rate of less than 4% for this step. From the
misclassification error rates estimated from the three sam-
ples of records used for quality assurance purposes, the
estimated total number of misclassified reports was 587
(2.7% of the 21,731 records studied).
Proportion of inconclusive scans
In the GP group, there were 9175 records of ultrasound
scans with reports which referred to the liver or lobes
and, of these, 746 records reported the presence of an FLL
(8.1%; 95% CI 7.6% to 8.7%). The proportions of inconclu-
sive, malignant and benign FLL scans are reported in
Table 3, with 18.4% (95% CI 15.7% to 21.3%) of scans
being classified as inconclusive. Of the benign FLLs, 252
were cysts; if these were not classified as FLLs, the propor-
tion of inconclusive scans was 27.7% (95% CI 23.7% to
31.8%). Only 11 malignant lesions were positively identified
in records from the GP cohort, with 10 of these being diag-
nosed as metastases.
In the OP group, there were 12,556 records of ultrasound
scans with reports which referred to the liver or lobes,
with 1437 reports identifying an FLL (11.4%, 95%
CI 10.9% to 12.0%). The proportion of inconclusive, malig-
nant and benign FLL scans are reported in Table 3, with
29.4% (95% CI 26.9% to 32.1%) being inconclusive. Of the
benign FLLs, 460 were cysts; if these were not classified as
FLLs, the proportion of inconclusive scans was 43.3% (95%
CI 40.0% to 46.7%). A total of 107 scans were classified
as malignant in the OP group accounting for 7.4% (95%
CI 4.9% to 10.1%). Of these, 91 (85%) were classified as
metastatic.
A direct comparison of the GP and OP reports was
not made, because the study population scanned were
considered to be too heterogeneous for meaningful
evaluation.
Sub-group analysis of cirrhotic livers
From the GP cohort, only two of the 746 reports in which an
FLL was identified also mentioned the presence of cirrhosis.
In the OP cohort, 154 reports of the 1437 in which an FLL
was identified also mentioned cirrhosis (10.8%; 95% CI 9.2%
to 12.5%). The numbers of reports that mentioned FLLs
in the OP cohort, grouped by scan finding, are shown in
Table 4. Of the patients who had an identified FLL and also
had a diagnosis of cirrhosis, 47.4% (95% CI 39.3% to 55.6%)
of scans were reported to be inconclusive. In patients who
had an FLL identified but cirrhosis was not mentioned,
27.3% (95% CI 24.9% to 29.8%) were classified as inconclu-
sive. The probability of having an inconclusive scan was
significantly associated with the presence of cirrhosis,
with an odds ratio of 2.4 (95% CI 1.7% to 3.4%).
Discussion
Main study findings
Inconclusive test results are a frequent, but often over-
looked, feature of many diagnostic investigations.9 In this
study, we reported the results of a large retrospective study
which had the primary aim of understanding what propor-
tion of unenhanced ultrasound liver scans, in which an FLL
was detected, were inconclusive. This study was designed
and implemented to inform a future update of the NICE
diagnostic guidance (DG5) of SonoVue sulphur hexafluor-
ide microbubbles ultrasound contrast agent,2 which had
originally estimated that 43% of FLLs were inconclusive
in a cirrhosis surveillance cohort, aligned with the study
by Strobel et al.6 To the best of our knowledge, this is the
first time a large retrospective study has been used to quan-
tify the proportion of inconclusive scans in which an FLL
was detected by ultrasound of the liver. The methodology
developed to measure this outcome has been extensively
quality assured and appears robust, with an estimated com-
bined accuracy rate of automatic filtering and manual ana-
lysis of around 97%.
In our study, around 18% of scans of livers with identi-
fied FLLs in the GP cohort and around 29% in the OP cohort
were described as inconclusive by the operator. These fig-
ures included counting cysts as benign lesions.10 However,
although ultrasound is often considered to be the modality
of choice for detecting liver cysts, cystic lesions may not
always be interpreted as an FLL in practice,10,11 which
was verified by our survey of sonographers. Using an
Table 3 Totals and proportions of inconclusive, malignant and benign ultrasound scans reporting FLLs from GP and OP referred cohorts
Cohort Inconclusive FLL Malignant FLL Benign FLL* Total
GP (n) 137 11 598 746
(% FLLs) 18.4 (15.7–21.3) 1.5 (0.0–4.4) 80.2 (77.5–83.1) 100.0
OP (n) 423 107 907 1437
(% FLLs) 29.4 (26.9 to 32.1) 7.4 (4.9 to 10.1) 63.1 (60.6–65.7) 100.0
*Including cysts
Proportions are expressed as percentages (95% confidence interval)
Table 4 Numbers of reports that mentioned FLLs in the out-patient
cohort, grouped by scan finding (FLL conclusive or inconclusive) and
cirrhotic status
Scan finding
Have
cirrhosis
Do not have
cirrhosis Total
Inconclusive 73 350 423
Conclusive (benign or malignant) 81 933 1014
Total 154 1283 1437
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alternative assumption that cysts are not classified by sono-
graphers as FLLs, the proportion of inconclusive scans was
28% (GP) and 43% (OP), respectively. The latter figure is
close to the estimate used in the HTA to inform NICE guid-
ance.3 However, although the proportion of inconclusive
scans was the same in this case, the relative proportions
of benign and malignant scans were different, again illus-
trating the uncertainties concerning lesion definition and
the population the analysis is drawn from.
Whilst there is very little information in the literature con-
cerning the proportion of FLLs that are inconclusive in unen-
hanced ultrasound scans, we did identify a randomized
controlled trial by Trillaud et al.,12 in which 134 patients
with a previously detected FLL had the lesion characterised
as malignant, benign, or indeterminate using unenhanced
ultrasound, CEUS, CECT, CEMRI, and/or histopathology.
The final diagnosis (gold standard) was adjudicated using a
combination of imaging and histopathological results, and
clinical information. The proportion of inconclusive FLLs
was specifically recorded for all modalities, including base-
line ultrasonography, and this was measured as 60.6% (esti-
mated 95% CI of 52.1% to 69.1%), which is higher than
observed in the present study. The reasons for these differing
results are not known, but speculatively are likely to be
related to the population selection and the definition of
FLL. For instance, although cysts were recorded as a category
of benign FLL in this study, none of the patients were
reported as having one in the RCT.
An important factor likely to influence the proportion of
inconclusive scans is the population of patients that are
scanned. In our study, we included patients referred from
GP and OP cohorts, and found that they were different,
with GP referrals less likely to yield inconclusive results.
The reasons for this are likely to be because the case-mix
was different in each group, with some patients in the OP
group being on liver surveillance programmes, and likely to
have been scanned several times (this was a retrospective
study of individual scans, not patients). Scans resulting
from GP referrals on the other hand are more likely to be
de novo referrals and be more representative of true inci-
dental findings of FLLs and their characterisation.
One aspect of the case-mix that was investigated was the
presence of cirrhosis, which was much more prevalent in
the OP cohort, as expected (i.e. the GP cohort showed better
parenchymal health). Sub-analysis of this group showed the
FLLs were more than twice as likely (OR 2.4) to be classified
as inconclusive in cirrhotic livers as in non-cirrhotic livers.
This result is likely to reflect the known features of cirrhosis,
which modifies the liver parenchymal architecture, and
causes distortion of ultrasound attenuation.1 Additionally,
unenhanced ultrasound may not be capable of differentiat-
ing hepatocellular carcinoma from other benign lesions,13
particularly regenerative nodules.14 The use of CEUS to
characterise FLLs in patients with cirrhosis is thus a par-
ticularly useful application of the technology.13
Advantages and limitations of study design
A retrospective review of radiology reports was selected as
the most appropriate study design to quantify the
proportion of inconclusive unenhanced ultrasound scans,
because this was primarily a measurement rather than a
comparative study, and more complex study designs
would not be necessary. As there was no comparator, con-
founding was not an issue. This study type has several
advantages compared with other observational studies,
not least because the data already exists, so it can be
accessed with little or no ethical concerns, as long as the
data remains anonymised. An alternative approach would
be a prospective study, but this carries the risk of cognitive
bias and inducing an operator-related Hawthorne effect.15
Additionally, this study had the advantage of being rela-
tively quick to perform, which was a requirement of
NICE who have need of rapid research facilitation in
order to inform updates of guidance. As the database is
fully inclusive of all NHS patients who receive ultrasound
in a single defined hospital trust, there is also little risk of
selection bias contributing to this measurement. Thus, it
could be considered that this was a pragmatic study reflect-
ing real-life practice, and the methodology employed in this
study could be used on data from other hospitals and for
other conditions.
In this case, the RIS database contains a wealth of infor-
mation and more detailed analysis, or follow-up analysis,
remains an option. For instance, a future study could follow
up individual patients in RIS to identify misdiagnoses (e.g.
lesions identified as metastases later found to be haemangi-
oma), and therefore estimate the diagnostic accuracy of
unenhanced ultrasound.
Nevertheless, there are also clear limitations to this meth-
odology, and the risk of several types of bias.16 As there
were too many primary records to feasibly read and cat-
egorise manually, a method of automatically analysing
report fields was devised to exclude reports that were out
of scope and to identify reports suggesting that no FLL had
been detected. Hence the only relevant records which were
manually read were those which could not be eliminated
automatically (Figure 1). However, quality assurance indi-
cated that approximately 3% of records (which were all
benign lesions) were inappropriately counted as ‘FLL not
detected’, which means the proportion of inconclusive
scans, and proportion of benign lesions in particular, in
the whole dataset was likely to have been underestimated
by this amount. Additionally, although patient inclusion
was universal, due to limited access to all data fields (to
preserve anonymity), it was not possible to stratify patients
to clinical conditions or other characteristics of interest, or to
investigate pre-specified factors not recorded by RIS. There
was also potential interpretation bias on behalf of the
researcher. For instance, often, on reading RIS reports,
there was clearly a degree of subjectivity when classifying
the categorical data, although the quality assurance under-
taken indicated that this was unlikely to be a significant
problem.
Conclusion
The results of this retrospective study indicate that, depend-
ing on the study population and the definition of FLL,
between 18 and 43% of FLLs that are detected are not
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diagnostically characterised by operators using unen-
hanced ultrasound. Higher proportions of inconclusive
scans were observed in scans taken from people referred
from OP departments compared with GP referrals, and
higher proportions in those with cirrhosis. These groups
in particular will routinely need additional imaging tech-
nologies to provide a definitive diagnosis, and CEUS is
likely to be a useful option for this.
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